nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluphenazine—CYP1A2—Imiquimod—skin cancer	0.14	0.223	CbGbCtD
Fluphenazine—CYP2E1—Dacarbazine—skin cancer	0.102	0.162	CbGbCtD
Fluphenazine—ABCB1—Vismodegib—skin cancer	0.085	0.135	CbGbCtD
Fluphenazine—CYP1A2—Vemurafenib—skin cancer	0.0769	0.122	CbGbCtD
Fluphenazine—CYP2D6—Vemurafenib—skin cancer	0.0633	0.101	CbGbCtD
Fluphenazine—CYP1A2—Dacarbazine—skin cancer	0.0589	0.0937	CbGbCtD
Fluphenazine—ABCB1—Dactinomycin—skin cancer	0.0447	0.0711	CbGbCtD
Fluphenazine—CYP1A2—Fluorouracil—skin cancer	0.0345	0.0549	CbGbCtD
Fluphenazine—ABCB1—Docetaxel—skin cancer	0.0231	0.0367	CbGbCtD
Fluphenazine—Edema cerebral—Temozolomide—skin cancer	0.00957	0.0651	CcSEcCtD
Fluphenazine—HRH1—nose—skin cancer	0.0083	0.0718	CbGeAlD
Fluphenazine—CALM2—ear—skin cancer	0.00521	0.045	CbGeAlD
Fluphenazine—CALM1—ear—skin cancer	0.00518	0.0448	CbGeAlD
Fluphenazine—Brain oedema—Temozolomide—skin cancer	0.00518	0.0352	CcSEcCtD
Fluphenazine—DRD1—nerve—skin cancer	0.0051	0.0441	CbGeAlD
Fluphenazine—Pigmentation disorder—Temozolomide—skin cancer	0.00444	0.0301	CcSEcCtD
Fluphenazine—CALM2—nerve—skin cancer	0.00328	0.0283	CbGeAlD
Fluphenazine—HTR2A—hindlimb—skin cancer	0.00327	0.0283	CbGeAlD
Fluphenazine—CALM1—nerve—skin cancer	0.00326	0.0282	CbGeAlD
Fluphenazine—DRD2—nerve—skin cancer	0.00301	0.0261	CbGeAlD
Fluphenazine—Parkinsonism—Fluorouracil—skin cancer	0.003	0.0204	CcSEcCtD
Fluphenazine—Tenderness—Imiquimod—skin cancer	0.00283	0.0192	CcSEcCtD
Fluphenazine—HTR2A—appendage—skin cancer	0.0028	0.0242	CbGeAlD
Fluphenazine—CALM2—endothelium—skin cancer	0.00279	0.0241	CbGeAlD
Fluphenazine—CALM1—endothelium—skin cancer	0.00278	0.024	CbGeAlD
Fluphenazine—CALM2—hair follicle—skin cancer	0.00274	0.0237	CbGeAlD
Fluphenazine—CALM2—blood vessel—skin cancer	0.00257	0.0223	CbGeAlD
Fluphenazine—CALM1—blood vessel—skin cancer	0.00256	0.0222	CbGeAlD
Fluphenazine—Photosensitivity—Vemurafenib—skin cancer	0.0024	0.0163	CcSEcCtD
Fluphenazine—CALM3—nipple—skin cancer	0.00237	0.0205	CbGeAlD
Fluphenazine—Tenderness—Bleomycin—skin cancer	0.00201	0.0137	CcSEcCtD
Fluphenazine—Eczema—Imiquimod—skin cancer	0.002	0.0136	CcSEcCtD
Fluphenazine—HTR2A—nerve—skin cancer	0.00199	0.0172	CbGeAlD
Fluphenazine—Muscle spasms—Vismodegib—skin cancer	0.00197	0.0134	CcSEcCtD
Fluphenazine—Nasal congestion—Imiquimod—skin cancer	0.00197	0.0134	CcSEcCtD
Fluphenazine—Extrapyramidal disorder—Temozolomide—skin cancer	0.00197	0.0134	CcSEcCtD
Fluphenazine—Dermatitis exfoliative—Imiquimod—skin cancer	0.0019	0.0129	CcSEcCtD
Fluphenazine—CALM2—nipple—skin cancer	0.00186	0.0161	CbGeAlD
Fluphenazine—CALM1—nipple—skin cancer	0.00185	0.016	CbGeAlD
Fluphenazine—CALM2—neck—skin cancer	0.00184	0.0159	CbGeAlD
Fluphenazine—CALM1—neck—skin cancer	0.00183	0.0159	CbGeAlD
Fluphenazine—Lethargy—Imiquimod—skin cancer	0.00183	0.0124	CcSEcCtD
Fluphenazine—Eosinophilia—Vemurafenib—skin cancer	0.0018	0.0122	CcSEcCtD
Fluphenazine—Systemic lupus erythematosus—Docetaxel—skin cancer	0.00178	0.0121	CcSEcCtD
Fluphenazine—Menstruation irregular—Docetaxel—skin cancer	0.00178	0.0121	CcSEcCtD
Fluphenazine—Liver injury—Temozolomide—skin cancer	0.00176	0.012	CcSEcCtD
Fluphenazine—HTR2A—endothelium—skin cancer	0.00169	0.0146	CbGeAlD
Fluphenazine—DRD3—head—skin cancer	0.00169	0.0146	CbGeAlD
Fluphenazine—Photosensitivity reaction—Vemurafenib—skin cancer	0.00166	0.0113	CcSEcCtD
Fluphenazine—HTR6—head—skin cancer	0.00163	0.0141	CbGeAlD
Fluphenazine—Skin disorder—Vismodegib—skin cancer	0.00163	0.011	CcSEcCtD
Fluphenazine—Tenderness—Fluorouracil—skin cancer	0.00156	0.0106	CcSEcCtD
Fluphenazine—HTR2A—blood vessel—skin cancer	0.00156	0.0135	CbGeAlD
Fluphenazine—Pancytopenia—Imiquimod—skin cancer	0.00147	0.01	CcSEcCtD
Fluphenazine—Decreased appetite—Vismodegib—skin cancer	0.00145	0.00988	CcSEcCtD
Fluphenazine—Leukocytosis—Fluorouracil—skin cancer	0.00145	0.00987	CcSEcCtD
Fluphenazine—CYP1A2—nipple—skin cancer	0.00144	0.0125	CbGeAlD
Fluphenazine—Upper respiratory tract infection—Imiquimod—skin cancer	0.00144	0.00979	CcSEcCtD
Fluphenazine—Oedema peripheral—Vemurafenib—skin cancer	0.00143	0.00974	CcSEcCtD
Fluphenazine—Constipation—Vismodegib—skin cancer	0.00143	0.00972	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Imiquimod—skin cancer	0.00142	0.00962	CcSEcCtD
Fluphenazine—CALM3—mammalian vulva—skin cancer	0.00138	0.012	CbGeAlD
Fluphenazine—HRH1—nipple—skin cancer	0.00135	0.0117	CbGeAlD
Fluphenazine—Dermatitis atopic—Docetaxel—skin cancer	0.00133	0.00904	CcSEcCtD
Fluphenazine—ADRA2A—nipple—skin cancer	0.00133	0.0115	CbGeAlD
Fluphenazine—CALM2—connective tissue—skin cancer	0.00132	0.0114	CbGeAlD
Fluphenazine—CALM1—connective tissue—skin cancer	0.00131	0.0114	CbGeAlD
Fluphenazine—Erythema—Vemurafenib—skin cancer	0.00127	0.00861	CcSEcCtD
Fluphenazine—CALM2—epithelium—skin cancer	0.00125	0.0108	CbGeAlD
Fluphenazine—CALM1—epithelium—skin cancer	0.00125	0.0108	CbGeAlD
Fluphenazine—Lethargy—Dactinomycin—skin cancer	0.00121	0.00824	CcSEcCtD
Fluphenazine—DRD1—head—skin cancer	0.00121	0.0105	CbGeAlD
Fluphenazine—CALM2—skin of body—skin cancer	0.00119	0.0103	CbGeAlD
Fluphenazine—CALM1—skin of body—skin cancer	0.00119	0.0103	CbGeAlD
Fluphenazine—Pruritus—Vismodegib—skin cancer	0.00118	0.00805	CcSEcCtD
Fluphenazine—Nasal congestion—Temozolomide—skin cancer	0.00118	0.00802	CcSEcCtD
Fluphenazine—Dermatitis exfoliative—Temozolomide—skin cancer	0.00114	0.00774	CcSEcCtD
Fluphenazine—Photosensitivity—Fluorouracil—skin cancer	0.00113	0.00767	CcSEcCtD
Fluphenazine—HTR2C—female reproductive system—skin cancer	0.00113	0.00973	CbGeAlD
Fluphenazine—HTR2A—neck—skin cancer	0.00112	0.00966	CbGeAlD
Fluphenazine—CALM2—mammalian vulva—skin cancer	0.00109	0.0094	CbGeAlD
Fluphenazine—CALM1—mammalian vulva—skin cancer	0.00108	0.00936	CbGeAlD
Fluphenazine—Erythema—Imiquimod—skin cancer	0.00108	0.00734	CcSEcCtD
Fluphenazine—Pancytopenia—Bleomycin—skin cancer	0.00105	0.00711	CcSEcCtD
Fluphenazine—Anaphylactic shock—Vemurafenib—skin cancer	0.00103	0.00703	CcSEcCtD
Fluphenazine—Dysphagia—Dactinomycin—skin cancer	0.00103	0.00698	CcSEcCtD
Fluphenazine—ABCB1—blood vessel—skin cancer	0.00102	0.00885	CbGeAlD
Fluphenazine—Lethargy—Fluorouracil—skin cancer	0.00101	0.00687	CcSEcCtD
Fluphenazine—Skin disorder—Vemurafenib—skin cancer	0.001	0.00682	CcSEcCtD
Fluphenazine—Nausea—Vismodegib—skin cancer	0.000994	0.00675	CcSEcCtD
Fluphenazine—Agitation—Imiquimod—skin cancer	0.000993	0.00675	CcSEcCtD
Fluphenazine—Pneumonia—Bleomycin—skin cancer	0.000988	0.00671	CcSEcCtD
Fluphenazine—Angioedema—Imiquimod—skin cancer	0.000987	0.00671	CcSEcCtD
Fluphenazine—Hepatocellular injury—Docetaxel—skin cancer	0.000985	0.00669	CcSEcCtD
Fluphenazine—Pancytopenia—Dactinomycin—skin cancer	0.000976	0.00663	CcSEcCtD
Fluphenazine—Hypotension—Vemurafenib—skin cancer	0.000966	0.00656	CcSEcCtD
Fluphenazine—CALM2—lymphoid tissue—skin cancer	0.000965	0.00835	CbGeAlD
Fluphenazine—CALM1—lymphoid tissue—skin cancer	0.000961	0.00831	CbGeAlD
Fluphenazine—HRH1—connective tissue—skin cancer	0.000958	0.00829	CbGeAlD
Fluphenazine—Cardiac arrest—Fluorouracil—skin cancer	0.000942	0.0064	CcSEcCtD
Fluphenazine—ADRA2A—connective tissue—skin cancer	0.000941	0.00814	CbGeAlD
Fluphenazine—HTR2C—head—skin cancer	0.00094	0.00813	CbGeAlD
Fluphenazine—Hypertension—Imiquimod—skin cancer	0.000933	0.00634	CcSEcCtD
Fluphenazine—CALM2—female reproductive system—skin cancer	0.000931	0.00805	CbGeAlD
Fluphenazine—Dysphagia—Temozolomide—skin cancer	0.000929	0.00631	CcSEcCtD
Fluphenazine—CALM1—female reproductive system—skin cancer	0.000926	0.00801	CbGeAlD
Fluphenazine—Pneumonia—Dactinomycin—skin cancer	0.000921	0.00626	CcSEcCtD
Fluphenazine—HRH1—epithelium—skin cancer	0.00091	0.00787	CbGeAlD
Fluphenazine—Dry mouth—Imiquimod—skin cancer	0.000899	0.00611	CcSEcCtD
Fluphenazine—Decreased appetite—Vemurafenib—skin cancer	0.000899	0.00611	CcSEcCtD
Fluphenazine—Constipation—Vemurafenib—skin cancer	0.000884	0.00601	CcSEcCtD
Fluphenazine—Pancytopenia—Temozolomide—skin cancer	0.000882	0.006	CcSEcCtD
Fluphenazine—Upper respiratory tract infection—Temozolomide—skin cancer	0.000863	0.00587	CcSEcCtD
Fluphenazine—Tachycardia—Imiquimod—skin cancer	0.00086	0.00585	CcSEcCtD
Fluphenazine—Skin disorder—Imiquimod—skin cancer	0.000856	0.00582	CcSEcCtD
Fluphenazine—Dysphagia—Fluorouracil—skin cancer	0.000856	0.00582	CcSEcCtD
Fluphenazine—Agranulocytosis—Dactinomycin—skin cancer	0.000855	0.00581	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Temozolomide—skin cancer	0.000848	0.00576	CcSEcCtD
Fluphenazine—Eosinophilia—Fluorouracil—skin cancer	0.000848	0.00576	CcSEcCtD
Fluphenazine—Pneumonia—Temozolomide—skin cancer	0.000833	0.00566	CcSEcCtD
Fluphenazine—Body temperature increased—Vemurafenib—skin cancer	0.000817	0.00555	CcSEcCtD
Fluphenazine—Pancytopenia—Fluorouracil—skin cancer	0.000813	0.00552	CcSEcCtD
Fluphenazine—HTR2A—connective tissue—skin cancer	0.0008	0.00692	CbGeAlD
Fluphenazine—Upper respiratory tract infection—Fluorouracil—skin cancer	0.000796	0.00541	CcSEcCtD
Fluphenazine—HTR1A—head—skin cancer	0.000791	0.00684	CbGeAlD
Fluphenazine—HRH1—mammalian vulva—skin cancer	0.000789	0.00682	CbGeAlD
Fluphenazine—Dyspnoea—Imiquimod—skin cancer	0.000786	0.00534	CcSEcCtD
Fluphenazine—Somnolence—Imiquimod—skin cancer	0.000784	0.00533	CcSEcCtD
Fluphenazine—Photosensitivity reaction—Fluorouracil—skin cancer	0.000781	0.00531	CcSEcCtD
Fluphenazine—CALM2—head—skin cancer	0.000778	0.00672	CbGeAlD
Fluphenazine—ADRA2A—mammalian vulva—skin cancer	0.000775	0.0067	CbGeAlD
Fluphenazine—CALM1—head—skin cancer	0.000774	0.00669	CbGeAlD
Fluphenazine—Pneumonia—Fluorouracil—skin cancer	0.000768	0.00522	CcSEcCtD
Fluphenazine—Erythema—Bleomycin—skin cancer	0.000767	0.00522	CcSEcCtD
Fluphenazine—Decreased appetite—Imiquimod—skin cancer	0.000766	0.00521	CcSEcCtD
Fluphenazine—Hypersensitivity—Vemurafenib—skin cancer	0.000762	0.00518	CcSEcCtD
Fluphenazine—HTR2A—epithelium—skin cancer	0.00076	0.00657	CbGeAlD
Fluphenazine—Oedema peripheral—Temozolomide—skin cancer	0.000733	0.00498	CcSEcCtD
Fluphenazine—Pruritus—Vemurafenib—skin cancer	0.000731	0.00497	CcSEcCtD
Fluphenazine—Lethargy—Docetaxel—skin cancer	0.000729	0.00496	CcSEcCtD
Fluphenazine—Erythema—Dactinomycin—skin cancer	0.000716	0.00486	CcSEcCtD
Fluphenazine—DRD2—head—skin cancer	0.000715	0.00618	CbGeAlD
Fluphenazine—Agranulocytosis—Fluorouracil—skin cancer	0.000712	0.00484	CcSEcCtD
Fluphenazine—Urticaria—Imiquimod—skin cancer	0.0007	0.00476	CcSEcCtD
Fluphenazine—Body temperature increased—Imiquimod—skin cancer	0.000697	0.00474	CcSEcCtD
Fluphenazine—CALM3—lymph node—skin cancer	0.000693	0.006	CbGeAlD
Fluphenazine—Leukopenia—Bleomycin—skin cancer	0.000687	0.00467	CcSEcCtD
Fluphenazine—HRH1—female reproductive system—skin cancer	0.000676	0.00584	CbGeAlD
Fluphenazine—CYP2E1—lymphoid tissue—skin cancer	0.000673	0.00582	CbGeAlD
Fluphenazine—ADRA2A—female reproductive system—skin cancer	0.000664	0.00574	CbGeAlD
Fluphenazine—Hypersensitivity—Imiquimod—skin cancer	0.00065	0.00441	CcSEcCtD
Fluphenazine—CYP2E1—female reproductive system—skin cancer	0.000649	0.00562	CbGeAlD
Fluphenazine—Headache—Vemurafenib—skin cancer	0.000648	0.0044	CcSEcCtD
Fluphenazine—Erythema—Temozolomide—skin cancer	0.000647	0.0044	CcSEcCtD
Fluphenazine—Leukopenia—Dactinomycin—skin cancer	0.000641	0.00435	CcSEcCtD
Fluphenazine—Anaphylactic shock—Bleomycin—skin cancer	0.000626	0.00426	CcSEcCtD
Fluphenazine—Pruritus—Imiquimod—skin cancer	0.000624	0.00424	CcSEcCtD
Fluphenazine—Dysphagia—Docetaxel—skin cancer	0.000618	0.0042	CcSEcCtD
Fluphenazine—Nausea—Vemurafenib—skin cancer	0.000614	0.00417	CcSEcCtD
Fluphenazine—Vision blurred—Temozolomide—skin cancer	0.00061	0.00415	CcSEcCtD
Fluphenazine—Erythema—Fluorouracil—skin cancer	0.000596	0.00405	CcSEcCtD
Fluphenazine—Agitation—Temozolomide—skin cancer	0.000595	0.00404	CcSEcCtD
Fluphenazine—Angioedema—Temozolomide—skin cancer	0.000592	0.00402	CcSEcCtD
Fluphenazine—Pancytopenia—Docetaxel—skin cancer	0.000587	0.00399	CcSEcCtD
Fluphenazine—Hypotension—Bleomycin—skin cancer	0.000585	0.00398	CcSEcCtD
Fluphenazine—Leukopenia—Temozolomide—skin cancer	0.000579	0.00394	CcSEcCtD
Fluphenazine—HRH1—head—skin cancer	0.000565	0.00488	CbGeAlD
Fluphenazine—HTR2A—female reproductive system—skin cancer	0.000564	0.00488	CbGeAlD
Fluphenazine—Vision blurred—Fluorouracil—skin cancer	0.000562	0.00382	CcSEcCtD
Fluphenazine—Hypertension—Temozolomide—skin cancer	0.000559	0.0038	CcSEcCtD
Fluphenazine—Dyspnoea—Bleomycin—skin cancer	0.000558	0.00379	CcSEcCtD
Fluphenazine—ADRA2A—head—skin cancer	0.000555	0.0048	CbGeAlD
Fluphenazine—Pneumonia—Docetaxel—skin cancer	0.000554	0.00377	CcSEcCtD
Fluphenazine—Headache—Imiquimod—skin cancer	0.000552	0.00375	CcSEcCtD
Fluphenazine—Decreased appetite—Bleomycin—skin cancer	0.000544	0.0037	CcSEcCtD
Fluphenazine—CALM2—lymph node—skin cancer	0.000544	0.00471	CbGeAlD
Fluphenazine—CYP2E1—head—skin cancer	0.000542	0.00469	CbGeAlD
Fluphenazine—CALM1—lymph node—skin cancer	0.000542	0.00469	CbGeAlD
Fluphenazine—Dry mouth—Temozolomide—skin cancer	0.000539	0.00366	CcSEcCtD
Fluphenazine—Leukopenia—Fluorouracil—skin cancer	0.000534	0.00363	CcSEcCtD
Fluphenazine—Anaphylactic shock—Temozolomide—skin cancer	0.000528	0.00359	CcSEcCtD
Fluphenazine—Nausea—Imiquimod—skin cancer	0.000524	0.00356	CcSEcCtD
Fluphenazine—CYP2D6—female reproductive system—skin cancer	0.000514	0.00445	CbGeAlD
Fluphenazine—Agranulocytosis—Docetaxel—skin cancer	0.000514	0.00349	CcSEcCtD
Fluphenazine—Skin disorder—Temozolomide—skin cancer	0.000513	0.00349	CcSEcCtD
Fluphenazine—Decreased appetite—Dactinomycin—skin cancer	0.000508	0.00345	CcSEcCtD
Fluphenazine—ABCB1—epithelium—skin cancer	0.000498	0.00431	CbGeAlD
Fluphenazine—Urticaria—Bleomycin—skin cancer	0.000498	0.00338	CcSEcCtD
Fluphenazine—Body temperature increased—Bleomycin—skin cancer	0.000495	0.00336	CcSEcCtD
Fluphenazine—Oedema peripheral—Docetaxel—skin cancer	0.000487	0.00331	CcSEcCtD
Fluphenazine—Anaphylactic shock—Fluorouracil—skin cancer	0.000487	0.00331	CcSEcCtD
Fluphenazine—Tachycardia—Fluorouracil—skin cancer	0.000475	0.00323	CcSEcCtD
Fluphenazine—HTR2A—head—skin cancer	0.000471	0.00408	CbGeAlD
Fluphenazine—Dyspnoea—Temozolomide—skin cancer	0.000471	0.0032	CcSEcCtD
Fluphenazine—Somnolence—Temozolomide—skin cancer	0.00047	0.00319	CcSEcCtD
Fluphenazine—Body temperature increased—Dactinomycin—skin cancer	0.000462	0.00314	CcSEcCtD
Fluphenazine—Hypersensitivity—Bleomycin—skin cancer	0.000461	0.00314	CcSEcCtD
Fluphenazine—Decreased appetite—Temozolomide—skin cancer	0.000459	0.00312	CcSEcCtD
Fluphenazine—Hypotension—Fluorouracil—skin cancer	0.000455	0.00309	CcSEcCtD
Fluphenazine—Constipation—Temozolomide—skin cancer	0.000452	0.00307	CcSEcCtD
Fluphenazine—Pruritus—Bleomycin—skin cancer	0.000443	0.00301	CcSEcCtD
Fluphenazine—Dyspnoea—Fluorouracil—skin cancer	0.000434	0.00295	CcSEcCtD
Fluphenazine—Somnolence—Fluorouracil—skin cancer	0.000433	0.00294	CcSEcCtD
Fluphenazine—ABCB1—mammalian vulva—skin cancer	0.000432	0.00373	CbGeAlD
Fluphenazine—Erythema—Docetaxel—skin cancer	0.000431	0.00293	CcSEcCtD
Fluphenazine—Hypersensitivity—Dactinomycin—skin cancer	0.00043	0.00292	CcSEcCtD
Fluphenazine—CYP2D6—head—skin cancer	0.00043	0.00371	CbGeAlD
Fluphenazine—Decreased appetite—Fluorouracil—skin cancer	0.000423	0.00288	CcSEcCtD
Fluphenazine—Urticaria—Temozolomide—skin cancer	0.00042	0.00285	CcSEcCtD
Fluphenazine—Body temperature increased—Temozolomide—skin cancer	0.000418	0.00284	CcSEcCtD
Fluphenazine—Muscle spasms—Docetaxel—skin cancer	0.000414	0.00281	CcSEcCtD
Fluphenazine—HRH1—lymph node—skin cancer	0.000395	0.00342	CbGeAlD
Fluphenazine—Hypersensitivity—Temozolomide—skin cancer	0.000389	0.00265	CcSEcCtD
Fluphenazine—ADRA2A—lymph node—skin cancer	0.000388	0.00336	CbGeAlD
Fluphenazine—Urticaria—Fluorouracil—skin cancer	0.000387	0.00263	CcSEcCtD
Fluphenazine—Leukopenia—Docetaxel—skin cancer	0.000385	0.00262	CcSEcCtD
Fluphenazine—Body temperature increased—Fluorouracil—skin cancer	0.000385	0.00262	CcSEcCtD
Fluphenazine—ABCB1—lymphoid tissue—skin cancer	0.000383	0.00332	CbGeAlD
Fluphenazine—Pruritus—Temozolomide—skin cancer	0.000374	0.00254	CcSEcCtD
Fluphenazine—Nausea—Bleomycin—skin cancer	0.000372	0.00253	CcSEcCtD
Fluphenazine—Hypertension—Docetaxel—skin cancer	0.000372	0.00253	CcSEcCtD
Fluphenazine—ABCB1—female reproductive system—skin cancer	0.00037	0.0032	CbGeAlD
Fluphenazine—Hypersensitivity—Fluorouracil—skin cancer	0.000359	0.00244	CcSEcCtD
Fluphenazine—Dry mouth—Docetaxel—skin cancer	0.000358	0.00244	CcSEcCtD
Fluphenazine—Anaphylactic shock—Docetaxel—skin cancer	0.000351	0.00239	CcSEcCtD
Fluphenazine—Nausea—Dactinomycin—skin cancer	0.000347	0.00236	CcSEcCtD
Fluphenazine—Pruritus—Fluorouracil—skin cancer	0.000344	0.00234	CcSEcCtD
Fluphenazine—Tachycardia—Docetaxel—skin cancer	0.000343	0.00233	CcSEcCtD
Fluphenazine—Skin disorder—Docetaxel—skin cancer	0.000341	0.00232	CcSEcCtD
Fluphenazine—Headache—Temozolomide—skin cancer	0.000331	0.00225	CcSEcCtD
Fluphenazine—Hypotension—Docetaxel—skin cancer	0.000328	0.00223	CcSEcCtD
Fluphenazine—Nausea—Temozolomide—skin cancer	0.000314	0.00213	CcSEcCtD
Fluphenazine—Dyspnoea—Docetaxel—skin cancer	0.000313	0.00213	CcSEcCtD
Fluphenazine—Somnolence—Docetaxel—skin cancer	0.000312	0.00212	CcSEcCtD
Fluphenazine—ABCB1—head—skin cancer	0.000309	0.00267	CbGeAlD
Fluphenazine—Decreased appetite—Docetaxel—skin cancer	0.000305	0.00208	CcSEcCtD
Fluphenazine—Headache—Fluorouracil—skin cancer	0.000305	0.00207	CcSEcCtD
Fluphenazine—Constipation—Docetaxel—skin cancer	0.0003	0.00204	CcSEcCtD
Fluphenazine—Nausea—Fluorouracil—skin cancer	0.000289	0.00196	CcSEcCtD
Fluphenazine—Body temperature increased—Docetaxel—skin cancer	0.000278	0.00189	CcSEcCtD
Fluphenazine—Hypersensitivity—Docetaxel—skin cancer	0.000259	0.00176	CcSEcCtD
Fluphenazine—Pruritus—Docetaxel—skin cancer	0.000249	0.00169	CcSEcCtD
Fluphenazine—Headache—Docetaxel—skin cancer	0.00022	0.0015	CcSEcCtD
Fluphenazine—ABCB1—lymph node—skin cancer	0.000216	0.00187	CbGeAlD
Fluphenazine—Nausea—Docetaxel—skin cancer	0.000209	0.00142	CcSEcCtD
Fluphenazine—CALM2—Signaling Pathways—SHH—skin cancer	2.8e-05	0.000258	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—SHH—skin cancer	2.8e-05	0.000258	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—RASA1—skin cancer	2.78e-05	0.000257	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—RASA1—skin cancer	2.78e-05	0.000257	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—SMO—skin cancer	2.75e-05	0.000253	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—PTCH1—skin cancer	2.75e-05	0.000253	CbGpPWpGaD
Fluphenazine—CALM3—Neuronal System—HRAS—skin cancer	2.73e-05	0.000251	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by NGF—HRAS—skin cancer	2.67e-05	0.000246	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—PTGER4—skin cancer	2.67e-05	0.000246	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—PTCH1—skin cancer	2.66e-05	0.000245	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—PTCH1—skin cancer	2.66e-05	0.000245	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—SMO—skin cancer	2.66e-05	0.000245	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—SMO—skin cancer	2.66e-05	0.000245	CbGpPWpGaD
Fluphenazine—CALM1—Neuronal System—HRAS—skin cancer	2.64e-05	0.000243	CbGpPWpGaD
Fluphenazine—CALM2—Neuronal System—HRAS—skin cancer	2.64e-05	0.000243	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—ENO2—skin cancer	2.63e-05	0.000242	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—FOXO4—skin cancer	2.59e-05	0.000239	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by NGF—HRAS—skin cancer	2.59e-05	0.000238	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by NGF—HRAS—skin cancer	2.59e-05	0.000238	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—PTGER4—skin cancer	2.59e-05	0.000238	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—PTGER4—skin cancer	2.59e-05	0.000238	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by NGF—IL6—skin cancer	2.56e-05	0.000236	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—TERT—skin cancer	2.56e-05	0.000236	CbGpPWpGaD
Fluphenazine—ADRA2A—Hemostasis—NRAS—skin cancer	2.54e-05	0.000234	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—TERT—skin cancer	2.52e-05	0.000233	CbGpPWpGaD
Fluphenazine—HTR6—Signaling by GPCR—NRAS—skin cancer	2.5e-05	0.000231	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by NGF—IL6—skin cancer	2.48e-05	0.000228	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by NGF—IL6—skin cancer	2.48e-05	0.000228	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—ENO2—skin cancer	2.47e-05	0.000228	CbGpPWpGaD
Fluphenazine—CALM3—Disease—ERCC2—skin cancer	2.4e-05	0.000221	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—FOXO4—skin cancer	2.36e-05	0.000218	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—BRAF—skin cancer	2.35e-05	0.000217	CbGpPWpGaD
Fluphenazine—CALM1—Disease—ERCC2—skin cancer	2.32e-05	0.000214	CbGpPWpGaD
Fluphenazine—CALM2—Disease—ERCC2—skin cancer	2.32e-05	0.000214	CbGpPWpGaD
Fluphenazine—CALM3—Hemostasis—NRAS—skin cancer	2.32e-05	0.000213	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—FOXO4—skin cancer	2.28e-05	0.000211	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—FOXO4—skin cancer	2.28e-05	0.000211	CbGpPWpGaD
Fluphenazine—CALM3—Disease—TERT—skin cancer	2.25e-05	0.000208	CbGpPWpGaD
Fluphenazine—CALM1—Hemostasis—NRAS—skin cancer	2.24e-05	0.000206	CbGpPWpGaD
Fluphenazine—CALM2—Hemostasis—NRAS—skin cancer	2.24e-05	0.000206	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—ERCC2—skin cancer	2.21e-05	0.000203	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—TERT—skin cancer	2.2e-05	0.000203	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—TERT—skin cancer	2.19e-05	0.000202	CbGpPWpGaD
Fluphenazine—ADRA2A—Hemostasis—KRAS—skin cancer	2.18e-05	0.000201	CbGpPWpGaD
Fluphenazine—CALM1—Disease—TERT—skin cancer	2.18e-05	0.000201	CbGpPWpGaD
Fluphenazine—CALM2—Disease—TERT—skin cancer	2.18e-05	0.000201	CbGpPWpGaD
Fluphenazine—DRD1—Signaling by GPCR—NRAS—skin cancer	2.15e-05	0.000199	CbGpPWpGaD
Fluphenazine—HTR6—Signaling by GPCR—KRAS—skin cancer	2.15e-05	0.000199	CbGpPWpGaD
Fluphenazine—DRD3—Signaling by GPCR—NRAS—skin cancer	2.13e-05	0.000196	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—ENO2—skin cancer	2.1e-05	0.000193	CbGpPWpGaD
Fluphenazine—CALM3—Innate Immune System—NRAS—skin cancer	2.08e-05	0.000192	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—BRAF—skin cancer	2.03e-05	0.000187	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—ERCC2—skin cancer	2.03e-05	0.000187	CbGpPWpGaD
Fluphenazine—CALM2—Innate Immune System—NRAS—skin cancer	2.02e-05	0.000186	CbGpPWpGaD
Fluphenazine—CALM1—Innate Immune System—NRAS—skin cancer	2.02e-05	0.000186	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—ERCC2—skin cancer	2.01e-05	0.000185	CbGpPWpGaD
Fluphenazine—CALM3—Adaptive Immune System—NRAS—skin cancer	2e-05	0.000184	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—BRAF—skin cancer	2e-05	0.000184	CbGpPWpGaD
Fluphenazine—CALM3—Hemostasis—KRAS—skin cancer	1.99e-05	0.000184	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—ERCC2—skin cancer	1.95e-05	0.000179	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—ERCC2—skin cancer	1.95e-05	0.000179	CbGpPWpGaD
Fluphenazine—ADRA2A—Hemostasis—TP53—skin cancer	1.94e-05	0.000179	CbGpPWpGaD
Fluphenazine—CALM2—Adaptive Immune System—NRAS—skin cancer	1.94e-05	0.000178	CbGpPWpGaD
Fluphenazine—CALM1—Adaptive Immune System—NRAS—skin cancer	1.94e-05	0.000178	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—TERT—skin cancer	1.93e-05	0.000178	CbGpPWpGaD
Fluphenazine—CALM2—Hemostasis—KRAS—skin cancer	1.93e-05	0.000178	CbGpPWpGaD
Fluphenazine—CALM1—Hemostasis—KRAS—skin cancer	1.93e-05	0.000178	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—TERT—skin cancer	1.9e-05	0.000175	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—TERT—skin cancer	1.9e-05	0.000175	CbGpPWpGaD
Fluphenazine—ADRA2A—Hemostasis—HRAS—skin cancer	1.86e-05	0.000171	CbGpPWpGaD
Fluphenazine—DRD1—Signaling by GPCR—KRAS—skin cancer	1.85e-05	0.000171	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling by GPCR—NRAS—skin cancer	1.85e-05	0.000171	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling by GPCR—NRAS—skin cancer	1.84e-05	0.00017	CbGpPWpGaD
Fluphenazine—HTR6—Signaling by GPCR—HRAS—skin cancer	1.83e-05	0.000169	CbGpPWpGaD
Fluphenazine—DRD3—Signaling by GPCR—KRAS—skin cancer	1.83e-05	0.000169	CbGpPWpGaD
Fluphenazine—CALM3—Innate Immune System—KRAS—skin cancer	1.79e-05	0.000165	CbGpPWpGaD
Fluphenazine—CALM3—Disease—BRAF—skin cancer	1.78e-05	0.000164	CbGpPWpGaD
Fluphenazine—CALM3—Hemostasis—TP53—skin cancer	1.77e-05	0.000163	CbGpPWpGaD
Fluphenazine—HTR6—Signaling by GPCR—IL6—skin cancer	1.75e-05	0.000162	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—BRAF—skin cancer	1.74e-05	0.000161	CbGpPWpGaD
Fluphenazine—CALM1—Innate Immune System—KRAS—skin cancer	1.74e-05	0.00016	CbGpPWpGaD
Fluphenazine—CALM2—Innate Immune System—KRAS—skin cancer	1.74e-05	0.00016	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—BRAF—skin cancer	1.73e-05	0.00016	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—TERT—skin cancer	1.73e-05	0.000159	CbGpPWpGaD
Fluphenazine—CALM2—Disease—BRAF—skin cancer	1.73e-05	0.000159	CbGpPWpGaD
Fluphenazine—CALM1—Disease—BRAF—skin cancer	1.73e-05	0.000159	CbGpPWpGaD
Fluphenazine—CALM3—Adaptive Immune System—KRAS—skin cancer	1.72e-05	0.000159	CbGpPWpGaD
Fluphenazine—CALM2—Hemostasis—TP53—skin cancer	1.71e-05	0.000158	CbGpPWpGaD
Fluphenazine—CALM1—Hemostasis—TP53—skin cancer	1.71e-05	0.000158	CbGpPWpGaD
Fluphenazine—CALM3—Hemostasis—HRAS—skin cancer	1.69e-05	0.000156	CbGpPWpGaD
Fluphenazine—CALM2—Adaptive Immune System—KRAS—skin cancer	1.67e-05	0.000154	CbGpPWpGaD
Fluphenazine—CALM1—Adaptive Immune System—KRAS—skin cancer	1.67e-05	0.000154	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.64e-05	0.000151	CbGpPWpGaD
Fluphenazine—CALM2—Hemostasis—HRAS—skin cancer	1.64e-05	0.000151	CbGpPWpGaD
Fluphenazine—CALM1—Hemostasis—HRAS—skin cancer	1.64e-05	0.000151	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—NRAS—skin cancer	1.63e-05	0.00015	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—NRAS—skin cancer	1.6e-05	0.000148	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—NRAS—skin cancer	1.6e-05	0.000147	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling by GPCR—KRAS—skin cancer	1.59e-05	0.000147	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling by GPCR—KRAS—skin cancer	1.59e-05	0.000146	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—TERT—skin cancer	1.58e-05	0.000145	CbGpPWpGaD
Fluphenazine—DRD1—Signaling by GPCR—HRAS—skin cancer	1.58e-05	0.000145	CbGpPWpGaD
Fluphenazine—DRD3—Signaling by GPCR—HRAS—skin cancer	1.56e-05	0.000143	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—BRAF—skin cancer	1.53e-05	0.000141	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—TERT—skin cancer	1.53e-05	0.000141	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—TERT—skin cancer	1.53e-05	0.000141	CbGpPWpGaD
Fluphenazine—CALM3—Innate Immune System—HRAS—skin cancer	1.53e-05	0.000141	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—ERCC2—skin cancer	1.53e-05	0.000141	CbGpPWpGaD
Fluphenazine—DRD1—Signaling by GPCR—IL6—skin cancer	1.51e-05	0.000139	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—BRAF—skin cancer	1.5e-05	0.000139	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—BRAF—skin cancer	1.5e-05	0.000138	CbGpPWpGaD
Fluphenazine—DRD3—Signaling by GPCR—IL6—skin cancer	1.49e-05	0.000137	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—NRAS—skin cancer	1.48e-05	0.000136	CbGpPWpGaD
Fluphenazine—CALM2—Innate Immune System—HRAS—skin cancer	1.48e-05	0.000136	CbGpPWpGaD
Fluphenazine—CALM1—Innate Immune System—HRAS—skin cancer	1.48e-05	0.000136	CbGpPWpGaD
Fluphenazine—CALM3—Adaptive Immune System—HRAS—skin cancer	1.46e-05	0.000135	CbGpPWpGaD
Fluphenazine—CALM3—Innate Immune System—IL6—skin cancer	1.46e-05	0.000135	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—NRAS—skin cancer	1.46e-05	0.000134	CbGpPWpGaD
Fluphenazine—CALM3—Disease—PTGS2—skin cancer	1.44e-05	0.000133	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—ERCC2—skin cancer	1.44e-05	0.000132	CbGpPWpGaD
Fluphenazine—CALM2—Adaptive Immune System—HRAS—skin cancer	1.42e-05	0.000131	CbGpPWpGaD
Fluphenazine—CALM1—Adaptive Immune System—HRAS—skin cancer	1.42e-05	0.000131	CbGpPWpGaD
Fluphenazine—CALM2—Innate Immune System—IL6—skin cancer	1.41e-05	0.00013	CbGpPWpGaD
Fluphenazine—CALM1—Innate Immune System—IL6—skin cancer	1.41e-05	0.00013	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—KRAS—skin cancer	1.4e-05	0.000129	CbGpPWpGaD
Fluphenazine—CALM2—Disease—PTGS2—skin cancer	1.39e-05	0.000128	CbGpPWpGaD
Fluphenazine—CALM1—Disease—PTGS2—skin cancer	1.39e-05	0.000128	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—KRAS—skin cancer	1.38e-05	0.000127	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—KRAS—skin cancer	1.37e-05	0.000127	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—BRAF—skin cancer	1.37e-05	0.000126	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling by GPCR—HRAS—skin cancer	1.36e-05	0.000125	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling by GPCR—HRAS—skin cancer	1.35e-05	0.000124	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—NRAS—skin cancer	1.33e-05	0.000122	CbGpPWpGaD
Fluphenazine—ADRA2A—Metabolism—PTGS2—skin cancer	1.32e-05	0.000122	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling by GPCR—IL6—skin cancer	1.3e-05	0.00012	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling by GPCR—IL6—skin cancer	1.29e-05	0.000119	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—NRAS—skin cancer	1.29e-05	0.000118	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—NRAS—skin cancer	1.29e-05	0.000118	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—NRAS—skin cancer	1.27e-05	0.000117	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—KRAS—skin cancer	1.27e-05	0.000117	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—NRAS—skin cancer	1.26e-05	0.000116	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—KRAS—skin cancer	1.25e-05	0.000116	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—BRAF—skin cancer	1.25e-05	0.000115	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—ERCC2—skin cancer	1.22e-05	0.000112	CbGpPWpGaD
Fluphenazine—CYP2E1—Metabolism—PTGS2—skin cancer	1.21e-05	0.000112	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—NRAS—skin cancer	1.21e-05	0.000112	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—BRAF—skin cancer	1.21e-05	0.000111	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—BRAF—skin cancer	1.21e-05	0.000111	CbGpPWpGaD
Fluphenazine—CALM3—Metabolism—PTGS2—skin cancer	1.21e-05	0.000111	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—HRAS—skin cancer	1.19e-05	0.00011	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—NRAS—skin cancer	1.17e-05	0.000108	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—NRAS—skin cancer	1.17e-05	0.000108	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—HRAS—skin cancer	1.17e-05	0.000108	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—HRAS—skin cancer	1.17e-05	0.000108	CbGpPWpGaD
Fluphenazine—CALM2—Metabolism—PTGS2—skin cancer	1.17e-05	0.000108	CbGpPWpGaD
Fluphenazine—CALM1—Metabolism—PTGS2—skin cancer	1.17e-05	0.000108	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—KRAS—skin cancer	1.14e-05	0.000105	CbGpPWpGaD
Fluphenazine—DRD2—Signaling by GPCR—IL6—skin cancer	1.14e-05	0.000105	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—TP53—skin cancer	1.13e-05	0.000104	CbGpPWpGaD
Fluphenazine—CALM3—Disease—NRAS—skin cancer	1.12e-05	0.000103	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling by GPCR—IL6—skin cancer	1.12e-05	0.000103	CbGpPWpGaD
Fluphenazine—HRH1—Signaling by GPCR—IL6—skin cancer	1.12e-05	0.000103	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—KRAS—skin cancer	1.11e-05	0.000102	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—KRAS—skin cancer	1.11e-05	0.000102	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—KRAS—skin cancer	1.1e-05	0.000101	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—NRAS—skin cancer	1.09e-05	0.000101	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—NRAS—skin cancer	1.09e-05	0.0001	CbGpPWpGaD
Fluphenazine—CALM1—Disease—NRAS—skin cancer	1.08e-05	9.99e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—NRAS—skin cancer	1.08e-05	9.99e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—HRAS—skin cancer	1.08e-05	9.97e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—KRAS—skin cancer	1.08e-05	9.96e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—HRAS—skin cancer	1.07e-05	9.82e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—KRAS—skin cancer	1.05e-05	9.63e-05	CbGpPWpGaD
Fluphenazine—HTR6—Signaling Pathways—IL6—skin cancer	1.04e-05	9.54e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling by GPCR—IL6—skin cancer	1.02e-05	9.4e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—KRAS—skin cancer	1.01e-05	9.32e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—KRAS—skin cancer	1.01e-05	9.32e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—TP53—skin cancer	9.74e-06	8.97e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—HRAS—skin cancer	9.72e-06	8.96e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—KRAS—skin cancer	9.65e-06	8.89e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—NRAS—skin cancer	9.61e-06	8.86e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—TP53—skin cancer	9.61e-06	8.86e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—NRAS—skin cancer	9.46e-06	8.72e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—NRAS—skin cancer	9.44e-06	8.7e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—KRAS—skin cancer	9.42e-06	8.68e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—HRAS—skin cancer	9.4e-06	8.67e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—HRAS—skin cancer	9.4e-06	8.67e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—KRAS—skin cancer	9.37e-06	8.64e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—KRAS—skin cancer	9.33e-06	8.6e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—KRAS—skin cancer	9.33e-06	8.6e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—HRAS—skin cancer	9.31e-06	8.58e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling by GPCR—IL6—skin cancer	9.3e-06	8.58e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—HRAS—skin cancer	9.19e-06	8.47e-05	CbGpPWpGaD
Fluphenazine—ABCB1—Metabolism—PTGS2—skin cancer	9.14e-06	8.43e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling by GPCR—IL6—skin cancer	9e-06	8.3e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling by GPCR—IL6—skin cancer	9e-06	8.3e-05	CbGpPWpGaD
Fluphenazine—DRD1—Signaling Pathways—IL6—skin cancer	8.91e-06	8.22e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—HRAS—skin cancer	8.88e-06	8.19e-05	CbGpPWpGaD
Fluphenazine—DRD3—Signaling Pathways—IL6—skin cancer	8.79e-06	8.11e-05	CbGpPWpGaD
Fluphenazine—CYP2D6—Metabolism—PTGS2—skin cancer	8.62e-06	7.94e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—NRAS—skin cancer	8.6e-06	7.93e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—HRAS—skin cancer	8.59e-06	7.92e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—HRAS—skin cancer	8.59e-06	7.92e-05	CbGpPWpGaD
Fluphenazine—CALM3—Immune System—IL6—skin cancer	8.5e-06	7.84e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—TP53—skin cancer	8.37e-06	7.72e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—TP53—skin cancer	8.33e-06	7.68e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—KRAS—skin cancer	8.27e-06	7.62e-05	CbGpPWpGaD
Fluphenazine—CALM2—Immune System—IL6—skin cancer	8.22e-06	7.58e-05	CbGpPWpGaD
Fluphenazine—CALM1—Immune System—IL6—skin cancer	8.22e-06	7.58e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—HRAS—skin cancer	8.2e-06	7.56e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—KRAS—skin cancer	8.14e-06	7.5e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—KRAS—skin cancer	8.12e-06	7.49e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—HRAS—skin cancer	8.01e-06	7.38e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—HRAS—skin cancer	7.97e-06	7.34e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—HRAS—skin cancer	7.93e-06	7.31e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—HRAS—skin cancer	7.93e-06	7.31e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—NRAS—skin cancer	7.85e-06	7.24e-05	CbGpPWpGaD
Fluphenazine—CALM3—Disease—IL6—skin cancer	7.85e-06	7.23e-05	CbGpPWpGaD
Fluphenazine—HTR1A—Signaling Pathways—IL6—skin cancer	7.66e-06	7.06e-05	CbGpPWpGaD
Fluphenazine—HTR2C—Signaling Pathways—IL6—skin cancer	7.63e-06	7.03e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—NRAS—skin cancer	7.59e-06	7e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—NRAS—skin cancer	7.59e-06	7e-05	CbGpPWpGaD
Fluphenazine—CALM1—Disease—IL6—skin cancer	7.59e-06	7e-05	CbGpPWpGaD
Fluphenazine—CALM2—Disease—IL6—skin cancer	7.59e-06	7e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—KRAS—skin cancer	7.4e-06	6.82e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—TP53—skin cancer	7.35e-06	6.78e-05	CbGpPWpGaD
Fluphenazine—CYP1A2—Metabolism—PTGS2—skin cancer	7.3e-06	6.73e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—TP53—skin cancer	7.23e-06	6.67e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—TP53—skin cancer	7.22e-06	6.65e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—HRAS—skin cancer	7.03e-06	6.48e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—HRAS—skin cancer	6.92e-06	6.38e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—HRAS—skin cancer	6.9e-06	6.36e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—KRAS—skin cancer	6.76e-06	6.23e-05	CbGpPWpGaD
Fluphenazine—DRD2—Signaling Pathways—IL6—skin cancer	6.73e-06	6.2e-05	CbGpPWpGaD
Fluphenazine—HTR2A—Signaling Pathways—IL6—skin cancer	6.62e-06	6.1e-05	CbGpPWpGaD
Fluphenazine—HRH1—Signaling Pathways—IL6—skin cancer	6.61e-06	6.09e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—TP53—skin cancer	6.58e-06	6.07e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—KRAS—skin cancer	6.54e-06	6.02e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—KRAS—skin cancer	6.54e-06	6.02e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—HRAS—skin cancer	6.29e-06	5.8e-05	CbGpPWpGaD
Fluphenazine—ADRA2A—Signaling Pathways—IL6—skin cancer	6.02e-06	5.55e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—TP53—skin cancer	6.01e-06	5.53e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—TP53—skin cancer	5.81e-06	5.35e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—TP53—skin cancer	5.81e-06	5.35e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—HRAS—skin cancer	5.74e-06	5.29e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—HRAS—skin cancer	5.56e-06	5.12e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—HRAS—skin cancer	5.56e-06	5.12e-05	CbGpPWpGaD
Fluphenazine—CALM3—Signaling Pathways—IL6—skin cancer	5.5e-06	5.07e-05	CbGpPWpGaD
Fluphenazine—CALM2—Signaling Pathways—IL6—skin cancer	5.32e-06	4.9e-05	CbGpPWpGaD
Fluphenazine—CALM1—Signaling Pathways—IL6—skin cancer	5.32e-06	4.9e-05	CbGpPWpGaD
